American Brachytherapy Society recommends no change for prostate permanent implant dose prescriptions using iodine-125 or palladium-103

Radiation oncologists should continue to prescribe monotherapy doses of 145 Gy and 125 Gy for 125I and 103Pd, respectively, and standard boost doses of 100-110 Gy and 90-100 Gy for 125I and 103Pd, respectively.